CHALLENGES IN THE MANAGEMENT OF EARLY MULTIPLE SCLEROSIS IN A 5-YEAR-OLD CHILD: A CASE REPORT
DOI:
https://doi.org/10.47820/recima21.v3i12.2247Palavras-chave:
Multiple Sclerosis, Autoimmune diseaseResumo
Our study reports the case of a child with early Multiple Sclerosis. It is an inflammatory disease of the Central Nervous System more common in adults, considered very rare in the first decade of life. The patient had 5 years old when suffered acute attacks of ataxia and paparesis. Magnetic resonance imaging of the brain showed lesions compatible with the disease, although the cerebrospinal fluid did not detected typical changes. There was recovery from outbreaks and had difficulties to use immunomodulatory treatment. It reflects that the diagnosis and management in children and adolescents is more difficult, as they present nonspecific symptoms that open a range of different differential diagnoses. Therefore, our report highlights the differences between multiple sclerosis in adults and children and the difficulties in this specific population.
Downloads
Referências
Wendel‐Haga M, Celius E. Is the hygiene hypothesis relevant for the risk of multiple sclerosis? Acta Neurologica Scandinavica 2017;136:26-30.
Brenton JN, Kammeyer R, Gluck L, Schreiner T, Makhani N. Multiple Sclerosis in Children: Current and Emerging Concepts. Seminars in neurology; 2020: Thieme Medical Publishers: 192-200.
da Gama ABCN, Lacativa MCS, da Costa Pereira FFC, Alvarenga RMP. Prevalence of multiple sclerosis in Brazil: A systematic review. Multiple sclerosis and related disorders 2015;4:572-579.
Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Revue neurologique 2016;172:3-13.
Lassmann H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Frontiers in Immunology 2019:3116.
Sommer RC, Hata J, de Medeiros Rimkus C, da Costa BK, Nakahara J, Sato DK. Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis. Multiple Sclerosis and Related Disorders 2021:103407.
Hung P-C, Wang H-S, Chou M-L, Lin K-L, Hsieh M-Y, Wong AM. Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients. Neuropediatrics 2012;43:064-071.
An Q, Fan C, Xu S. Childhood multiple sclerosis: clinical features and recent developments on treatment choices and outcomes. Eur Rev Med Pharmacol Sci 2018;22:5747-5754.
McKay KA, Hillert J, Manouchehrinia A. Long-term disability progression of pediatric-onset multiple sclerosis. Neurology 2019;92:e2764-e2773.
Alroughani R, Boyko A. Pediatric multiple sclerosis: a review. BMC neurology 2018;18:1-8.
Mirza A, Forbes JD, Zhu F, et al. The multiple sclerosis gut microbiota: A systematic review. Multiple Sclerosis and Related Disorders 2020;37:101427.
Tremlett H, Waubant E. The gut microbiota and pediatric multiple sclerosis: recent findings. Neurotherapeutics 2018;15:102-108.
Eskandarieh S, Sahraiain MA, Molazadeh N, Moghadasi AN. Pediatric multiple sclerosis and its familial recurrence: a population based study (1999–2017). Multiple sclerosis and related disorders 2019;36:101377.
Luca M, Ortega-Castro N, Patti F. Paediatric Multiple Sclerosis: A Scoping Review of Patients’ and Parents’ Perspectives. Children 2021;9:11.
Duquette P, Murray TJ, Pleines J, et al. Multiple sclerosis in childhood: clinical profile in 125 patients. The Journal of pediatrics 1987;111:359-363.
Forrester MB, Coleman L, Kornberg AJ. Multiple sclerosis in childhood: clinical and radiological features. Journal of child neurology 2009;24:56-62.
Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of neurology 2009;66:54-59.
Benson L, Healy B, Gorman M, et al. Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Multiple sclerosis and related disorders 2014;3:186-193.
Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: a longitudinal study. Neurology 2002;59:1006-1010.
Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. New England Journal of Medicine 2007;356:2603-2613.
Amato MP, Krupp LB, Charvet LE, Penner I, Till C. Pediatric multiple sclerosis: cognition and mood. Neurology 2016;87:S82-S87.
Banwell B, Reder A, Krupp L, et al. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 2006;66:472-476.
Tenembaum SN, Banwell B, Pohl D, et al. Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study. Journal of child neurology 2013;28:849-856.
Waubant E, Hietpas J, Stewart T, et al. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 2001;32:211-213.
Kornek B, Bernert G, Balassy C, Geldner J, Prayer D, Feucht M. Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics 2003;34:120-126.
Baroncini D, Zaffaroni M, Moiola L, et al. Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: a multicentre, Italian, retrospective, observational study. Multiple Sclerosis Journal 2019;25:399-407.
Huppke P, Huppke B, Ellenberger D, et al. Therapy of highly active pediatric multiple sclerosis. Multiple Sclerosis Journal 2019;25:72-80.
Downloads
Publicado
Edição
Seção
Categorias
Licença
Copyright (c) 2022 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
